A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
Development and validation of a risk assessment scale for hepatic encephalopathy in cirrhotic patients
[post]
2019
unpublished
This study aims to develop a risk assessment scale to assess and quantify risk of hepatic encephalopathy in cirrhotic patients. Methods: Data were derived from two Delphi rounds and a cross-sectional survey of 276 cirrhotic patients. The minimal consensus were a mean score 3.5 on a scale of 1 to 5, and a coe cient of variation 0.25. The reliability and validity of the scale were validated by a cross-sectional survey. Results: After two Delphi rounds and item analysis, a nal 23-item scale
doi:10.21203/rs.2.17653/v1
fatcat:zpzfs3qfrvd3lkn76dgq65nzji